Literature DB >> 32862865

Mini-Hyper-CVD Combinations for Older Adults: Results of Recent Trials and a Glimpse into the Future.

Marlise R Luskin1, Daniel J DeAngelo2.   

Abstract

Entities:  

Keywords:  Geriatric; acute lymphoblastic leukemia; blinatumomab; inotuzumab; venetoclax

Mesh：

Substances：

Year:  2020        PMID： 32862865     DOI： 10.1016/S2152-2650(20)30458-4

Source DB:  PubMed          Journal:  Clin Lymphoma Myeloma Leuk        ISSN： 2152-2669


× No keyword cloud information.
  3 in total

Review 1.  Targeting Apoptosis in ALL.

Authors:  Wesley M Smith; Daniel R Reed
Journal:  Curr Hematol Malig Rep       Date:  2022-05-11       Impact factor: 3.952

2.  SWOG 1318: A Phase II Trial of Blinatumomab Followed by POMP Maintenance in Older Patients With Newly Diagnosed Philadelphia Chromosome-Negative B-Cell Acute Lymphoblastic Leukemia.

Authors:  Anjali S Advani; Anna Moseley; Kristen M O'Dwyer; Brent L Wood; Min Fang; Matthew J Wieduwilt; Ibrahim Aldoss; Jae H Park; Rebecca B Klisovic; Maria R Baer; Wendy Stock; Rupali R Bhave; Megan Othus; Richard C Harvey; Cheryl L Willman; Mark R Litzow; Richard M Stone; Elad Sharon; Harry P Erba
Journal:  J Clin Oncol       Date:  2022-02-14       Impact factor: 50.717

3.  Adding venetoclax to fludarabine/busulfan RIC transplant for high-risk MDS and AML is feasible, safe, and active.

Authors:  Jacqueline S Garcia; Haesook T Kim; H Moses Murdock; Corey S Cutler; Jennifer Brock; Mahasweta Gooptu; Vincent T Ho; John Koreth; Sarah Nikiforow; Rizwan Romee; Roman Shapiro; Fiona Loschi; Jeremy Ryan; Geoffrey Fell; Hannah Q Karp; Fabienne Lucas; Annette S Kim; Danielle Potter; Thelma Mashaka; Richard M Stone; Daniel J DeAngelo; Anthony Letai; R Coleman Lindsley; Robert J Soiffer; Joseph H Antin
Journal:  Blood Adv       Date:  2021-12-28
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.